User Auth Test Page

Rates Of Both Individual Mutations, Clinically Relevant Transmitted Drug Resistance Low Among People Newly Diagnosed With HIV Who Were Not Previously On ART, Study Finds

Healio (1/9, Stulpin) reports, “Rates of both individual mutations and clinically relevant transmitted drug resistance were low among people newly diagnosed with HIV who were not previously on ART, according to a...study.” For this study published in Clin...

Full Article
Clostridium Difficile Infection Tied To Longer Hospital Stays, Higher Mortality Rates For Patients With Intestinal Transplantations, Study Finds

HCPlive (1/9, Walter) reports, “A clostridium difficile infection (CDI) is linked to longer hospital stays and higher mortality rates for patients with intestinal transplantations,” according to a study that “used data from the National Readmission Databa...

Full Article
Omicron Subvariant XBB.1.5 Becoming Dominant Strain In Parts Of US

The Washington Post (1/8, A1, Nirappil, Weber) reports Omicron subvariant XBB.1.5 “is quickly becoming the dominant strain in parts of the United States because of a potent mix of mutations that makes it easier to spread broadly, including among those who...

Full Article
Rapid At-Home Tests For Respiratory Illnesses Lacking In US

NBC News (1/6, Bendix) reported that “unlike COVID tests...RSV and flu tests must be performed at a doctor’s office or ordered via prescription,” and the FDA has not yet “authorized an at-home test that can rapidly detect all three viruses at once.” Howev...

Full Article
COVID-19 Rising In US As RSV, Influenza Numbers Decline

CNN (1/6, Goodman, McPhillips) reported that amid this cold and flu season in the US, “COVID-19, which had taken a back seat to” viruses including influenza and RSV, “is once again becoming a menace, and health officials are urging people to stay vigilant...

Full Article
FDA Says It Does Not Expect AstraZeneca’s COVID-19 Antibody Treatment To Protect Against Omicron Subvariant XBB.1.5

Reuters (1/6, Satija) reported the “Food and Drug Administration said on Friday it does not expect AstraZeneca’s COVID-19 antibody cocktail” tixagevimab/cilgavimab (Evusheld) “to provide protection against the Omicron subvariant XBB.1.5.” While the FDA “i...

Full Article
FDA Accepts For Priority Review Supplemental Biologics License Application For Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine For Use In Infants, Children

Healio (1/6) reported, “The FDA has accepted for priority review a supplemental biologics license application for Pfizer’s 20-valent pneumococcal conjugate vaccine for use in infants and children aged 6 weeks to 17 years, Pfizer announced.” This “20-valen...

Full Article
Health Experts Raise Concern Over Spread Of Omicron Subvariant XBB.1.5

USA Today (1/4, Weintraub) reports, “The latest COVID-19 variant to sweep across the country, XBB.1.5, doesn’t appear to cause more serious disease than its predecessors, experts say.” According to data from the Centers for Disease Control and Prevention,...

Full Article
COVID-19 Positivity Tied To Pneumococcal Carriage, Study Finds

Infectious Disease Advisor (1/4, Nye) reports a study published in Clinical Infectious Diseases found that “COVID-19 positivity was associated with pneumococcal carriage among all individuals...individuals with no COVID-19 symptoms...and with COVID-19 sym...

Full Article
Previous COVID-19 Infection Plus Vaccination Provides Most Robust Immunity Against Reinfection Among Adolescents, Case-Control Study Shows

Infectious Disease Advisor (1/4, Nye) reports, “Results of a case-control study...suggest previous COVID-19 infection plus vaccination provides the most robust immunity against reinfection among adolescents.” According to the results published in The Lanc...

Full Article
Single Jynneos Mpox Vaccine Dose Reduces Disease Severity, Hospitalization Risk, Study Finds

Healio (1/4, Feller) reports, “A single dose of the Jynneos mpox vaccine reduces hospitalization risk and disease severity, a study found, although researchers emphasized that people at risk for the disease should complete the two-dose vaccine series.” Ac...

Full Article
Global COVID-19 Vaccination Efforts Face Lack Of Demand Heading Into 2023

The Washington Post (1/4, Taylor) reports that increasingly, global COVID-19 vaccination efforts are facing a lack of demand. The Post adds, “Backers of Covax say they have seen a sharp decline in dose orders, including in countries with relatively low va...

Full Article
Antibody Drugs Have Potential To Address Infectious Diseases But Challenges Remain

The Washington Post (1/3, Johnson) reports, “Scientists see enormous potential in harnessing antibody drugs against an array of infectious-disease threats – if the costs come down.” Monoclonal antibody drugs “could be deployed to smother outbreaks, protec...

Full Article
Patients With Lower Respiratory Tract Infections And Low Procalcitonin Levels Treated With Placebo Improved At Rates Similar To Those Given Azithromycin In Study

Healio (1/3, Stulpin) reports, “Patients with lower respiratory tract infections and low procalcitonin levels treated with placebo improved at rates similar to those given azithromycin, with fewer side effects and less antibiotic exposure, a...study showe...

Full Article
Experts Warn Omicron Subvariant XBB.1.5 May Drive New Surge In US

CNN (1/3, Goodman) reports the result of the onset of “a slew of Omicron descendants” has “been a gradual rise in cases and hospitalizations.” However, on Friday, the “Centers for Disease Control and Prevention’s Covid-19 variant dashboard revealed a new...

Full Article
Oversight Of Medicare Drug Price Negotiations Among Top Priorities As Congress Returns

Bloomberg Law (1/3, Castronuovo, Ruoff, Subscription Publication) reports, “Overseeing Medicare’s new authority to negotiate prices of the country’s highest-spending drugs is among the top priorities for lawmakers as Congress returns to Washington.” In ad...

Full Article
Omicron Subvariant XBB.1.5 Becoming Dominant In US, Data Show

CNBC (12/30, Kimball) reported, “The Covid omicron XBB.1.5 variant is rapidly becoming dominant in the U.S. because it is highly immune evasive and appears more effective at binding to cells than related subvariants, scientists say.” The subvariant “now r...

Full Article
Medicare Spending On COVID-19 Testing Continued To Increase In 2022, Data Show

ProPublica (12/30, Damon) reported, “As the COVID-19 pandemic continues to churn, Medicare spending on testing for the virus continued to increase in 2022 and is outpacing the two prior years.” Through “Oct. 31, Medicare had spent $2 billion on COVID-19 t...

Full Article
COVID-19 Hospitalizations Rising In US As RSV, Flu Decline

NBC News (12/30, Lovelace) reported, “Covid hospitalizations are rising in the United States, even as hospitalizations for respiratory syncytial virus and the flu continue to fall.” The article added, “The seven-day average of daily Covid hospitalizations...

Full Article
Seasonal Flu Activity Remains High In US But Continuing To Decline, CDC Data Show

CNN (12/30, Howard) reported “seasonal flu activity remains high in the United States but continued to decline in most areas” in the week “leading up to Christmas, according to data published Friday by the US Centers for Disease Control and Prevention.” T...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

Rates Of Both Individual Mutations, Clinically Relevant Transmitted Drug Resistance Low Among People Newly Diagnosed With HIV Who Were Not Previously On ART, Study Finds

Clostridium Difficile Infection Tied To Longer Hospital Stays, Higher Mortality Rates For Patients With Intestinal Transplantations, Study Finds

Omicron Subvariant XBB.1.5 Becoming Dominant Strain In Parts Of US

Rapid At-Home Tests For Respiratory Illnesses Lacking In US

COVID-19 Rising In US As RSV, Influenza Numbers Decline

FDA Says It Does Not Expect AstraZeneca’s COVID-19 Antibody Treatment To Protect Against Omicron Subvariant XBB.1.5

FDA Accepts For Priority Review Supplemental Biologics License Application For Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine For Use In Infants, Children

Health Experts Raise Concern Over Spread Of Omicron Subvariant XBB.1.5

COVID-19 Positivity Tied To Pneumococcal Carriage, Study Finds

Previous COVID-19 Infection Plus Vaccination Provides Most Robust Immunity Against Reinfection Among Adolescents, Case-Control Study Shows

Single Jynneos Mpox Vaccine Dose Reduces Disease Severity, Hospitalization Risk, Study Finds

Global COVID-19 Vaccination Efforts Face Lack Of Demand Heading Into 2023

Antibody Drugs Have Potential To Address Infectious Diseases But Challenges Remain

Patients With Lower Respiratory Tract Infections And Low Procalcitonin Levels Treated With Placebo Improved At Rates Similar To Those Given Azithromycin In Study

Experts Warn Omicron Subvariant XBB.1.5 May Drive New Surge In US

Oversight Of Medicare Drug Price Negotiations Among Top Priorities As Congress Returns

Omicron Subvariant XBB.1.5 Becoming Dominant In US, Data Show

Medicare Spending On COVID-19 Testing Continued To Increase In 2022, Data Show

COVID-19 Hospitalizations Rising In US As RSV, Flu Decline

Seasonal Flu Activity Remains High In US But Continuing To Decline, CDC Data Show